84-2151-27 NBL1 (aa21-32) (Neuroblastoma, suppression of tumorigenicity 1, D1S1733E, DAN, DAND1, NB, NO3, DAN domain family member 1, Differential screening-selected gene aberrant in neuroblastoma, Neuroblastoma candidate region, suppression of tumorigenicity 1, Neuroblastoma) 100ug 208302
84-2151-27 NBL1 (aa21-32) (Neuroblastoma, suppression of tumorigenicity 1, D1S1733E, DAN, DAND1, NB, NO3, DAN domain family member 1, Differential screening-selected gene aberrant in neuroblastoma, Neuroblastoma candidate region, suppression of tumorigenicity 1, Neuroblastoma) 100ug 208302
NBL1 and anillin (ANLN) genes over-expression in pancreatic carcinoma.
Applications:Suitable for use in Peptide ELISA and Western Blot.
Other applications not tested.
Recommended Dilution:Peptide ELISA: 1:128,000Western Blot: 0.1-0.3ug/mlOptimal dilutions to be determined by the researcher.
Storage and Stability:May be stored at 4°C for short-term only.
Aliquot to avoid repeated freezing and thawing.
Store at -20°C.
Aliquots are stable for 12 months.
For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
Size：100ug
Host：goat
Source Antibody：human
Grade：Affinity Purified
Purity：Purified by immunoaffinity chromatography.
Form：Supplied as a liquid in Tris saline, pH 7.3, 0.5% BSA, 0.02% sodium azide.
Specificity：Recognizes human NBL1. This antibody is expected to recognize isoform 1 (NP_877421.2) only.
Isotype：IgG
Calc Applications Abbrev：E WB
Calc Crossreactivity：Hu
Immunogen：Synthetic peptide corresponding to aa21-32 from sequence C-KLGKTHGHRALE, at the internal region of the protein sequence according to NP_877421.2.
